nodes	percent_of_prediction	percent_of_DWPC	metapath
Nebivolol—ADRB1—coronary artery disease	0.214	0.543	CbGaD
Nebivolol—ADRB2—coronary artery disease	0.18	0.457	CbGaD
Nebivolol—ADRB2—Penbutolol—coronary artery disease	0.0767	0.19	CbGbCtD
Nebivolol—ADRB1—Penbutolol—coronary artery disease	0.0755	0.187	CbGbCtD
Nebivolol—HTR1A—Penbutolol—coronary artery disease	0.0605	0.15	CbGbCtD
Nebivolol—ADRB2—Timolol—coronary artery disease	0.054	0.134	CbGbCtD
Nebivolol—ADRB1—Timolol—coronary artery disease	0.0532	0.132	CbGbCtD
Nebivolol—CYP2D6—Niacin—coronary artery disease	0.0146	0.0361	CbGbCtD
Nebivolol—CYP2D6—Timolol—coronary artery disease	0.0136	0.0335	CbGbCtD
Nebivolol—CYP2D6—Captopril—coronary artery disease	0.0119	0.0295	CbGbCtD
Nebivolol—CYP2D6—Simvastatin—coronary artery disease	0.0115	0.0285	CbGbCtD
Nebivolol—CYP2D6—Pravastatin—coronary artery disease	0.0113	0.0279	CbGbCtD
Nebivolol—CYP2D6—Lovastatin—coronary artery disease	0.0113	0.0279	CbGbCtD
Nebivolol—CYP2D6—Atorvastatin—coronary artery disease	0.0103	0.0254	CbGbCtD
Nebivolol—Gastrointestinal pain—Telmisartan—coronary artery disease	0.000121	0.000825	CcSEcCtD
Nebivolol—Vertigo—Timolol—coronary artery disease	0.000121	0.000824	CcSEcCtD
Nebivolol—Somnolence—Furosemide—coronary artery disease	0.000121	0.000823	CcSEcCtD
Nebivolol—Syncope—Timolol—coronary artery disease	0.000121	0.000823	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Perindopril—coronary artery disease	0.00012	0.000822	CcSEcCtD
Nebivolol—Diarrhoea—Eplerenone—coronary artery disease	0.00012	0.000821	CcSEcCtD
Nebivolol—Fatigue—Perindopril—coronary artery disease	0.00012	0.000821	CcSEcCtD
Nebivolol—Urticaria—Trandolapril—coronary artery disease	0.000119	0.000816	CcSEcCtD
Nebivolol—Vomiting—Fenofibrate—coronary artery disease	0.000119	0.000814	CcSEcCtD
Nebivolol—Hypersensitivity—Valsartan—coronary artery disease	0.000119	0.000814	CcSEcCtD
Nebivolol—Urticaria—Enalapril—coronary artery disease	0.000119	0.000812	CcSEcCtD
Nebivolol—Abdominal pain—Trandolapril—coronary artery disease	0.000119	0.000812	CcSEcCtD
Nebivolol—Dizziness—Ezetimibe—coronary artery disease	0.000119	0.000811	CcSEcCtD
Nebivolol—Abdominal pain—Enalapril—coronary artery disease	0.000118	0.000808	CcSEcCtD
Nebivolol—Insomnia—Losartan—coronary artery disease	0.000118	0.000808	CcSEcCtD
Nebivolol—Rash—Fenofibrate—coronary artery disease	0.000118	0.000807	CcSEcCtD
Nebivolol—Dermatitis—Fenofibrate—coronary artery disease	0.000118	0.000807	CcSEcCtD
Nebivolol—Loss of consciousness—Timolol—coronary artery disease	0.000118	0.000806	CcSEcCtD
Nebivolol—Headache—Fenofibrate—coronary artery disease	0.000118	0.000802	CcSEcCtD
Nebivolol—Paraesthesia—Losartan—coronary artery disease	0.000117	0.000802	CcSEcCtD
Nebivolol—Gastrointestinal pain—Captopril—coronary artery disease	0.000117	0.000802	CcSEcCtD
Nebivolol—Urticaria—Telmisartan—coronary artery disease	0.000117	0.000801	CcSEcCtD
Nebivolol—Vomiting—Clopidogrel—coronary artery disease	0.000117	0.0008	CcSEcCtD
Nebivolol—Diarrhoea—Simvastatin—coronary artery disease	0.000117	0.0008	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Furosemide—coronary artery disease	0.000117	0.000799	CcSEcCtD
Nebivolol—Chest pain—Ramipril—coronary artery disease	0.000117	0.000799	CcSEcCtD
Nebivolol—Fatigue—Furosemide—coronary artery disease	0.000117	0.000798	CcSEcCtD
Nebivolol—Abdominal pain—Telmisartan—coronary artery disease	0.000117	0.000797	CcSEcCtD
Nebivolol—Dyspnoea—Losartan—coronary artery disease	0.000117	0.000796	CcSEcCtD
Nebivolol—Vomiting—Lovastatin—coronary artery disease	0.000116	0.000795	CcSEcCtD
Nebivolol—Somnolence—Losartan—coronary artery disease	0.000116	0.000794	CcSEcCtD
Nebivolol—Dizziness—Eplerenone—coronary artery disease	0.000116	0.000794	CcSEcCtD
Nebivolol—Rash—Clopidogrel—coronary artery disease	0.000116	0.000794	CcSEcCtD
Nebivolol—Unspecified disorder of skin and subcutaneous tissue—Ramipril—coronary artery disease	0.000116	0.000793	CcSEcCtD
Nebivolol—Dermatitis—Clopidogrel—coronary artery disease	0.000116	0.000793	CcSEcCtD
Nebivolol—Asthenia—Valsartan—coronary artery disease	0.000116	0.000792	CcSEcCtD
Nebivolol—Hypersensitivity—Niacin—coronary artery disease	0.000116	0.000791	CcSEcCtD
Nebivolol—Asthenia—Olmesartan—coronary artery disease	0.000116	0.000789	CcSEcCtD
Nebivolol—Headache—Clopidogrel—coronary artery disease	0.000116	0.000788	CcSEcCtD
Nebivolol—Rash—Lovastatin—coronary artery disease	0.000115	0.000788	CcSEcCtD
Nebivolol—Dermatitis—Lovastatin—coronary artery disease	0.000115	0.000788	CcSEcCtD
Nebivolol—Headache—Lovastatin—coronary artery disease	0.000115	0.000783	CcSEcCtD
Nebivolol—Pruritus—Valsartan—coronary artery disease	0.000114	0.000781	CcSEcCtD
Nebivolol—Chest pain—Timolol—coronary artery disease	0.000114	0.000781	CcSEcCtD
Nebivolol—Vomiting—Ezetimibe—coronary artery disease	0.000114	0.00078	CcSEcCtD
Nebivolol—Hypersensitivity—Pravastatin—coronary artery disease	0.000114	0.000779	CcSEcCtD
Nebivolol—Gastrointestinal pain—Perindopril—coronary artery disease	0.000114	0.000779	CcSEcCtD
Nebivolol—Angioedema—Lisinopril—coronary artery disease	0.000114	0.000778	CcSEcCtD
Nebivolol—Pruritus—Olmesartan—coronary artery disease	0.000114	0.000778	CcSEcCtD
Nebivolol—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	0.000114	0.000776	CcSEcCtD
Nebivolol—Abdominal pain—Captopril—coronary artery disease	0.000114	0.000775	CcSEcCtD
Nebivolol—Dizziness—Simvastatin—coronary artery disease	0.000113	0.000773	CcSEcCtD
Nebivolol—Rash—Ezetimibe—coronary artery disease	0.000113	0.000773	CcSEcCtD
Nebivolol—Dermatitis—Ezetimibe—coronary artery disease	0.000113	0.000772	CcSEcCtD
Nebivolol—Asthenia—Niacin—coronary artery disease	0.000113	0.00077	CcSEcCtD
Nebivolol—Fatigue—Losartan—coronary artery disease	0.000113	0.00077	CcSEcCtD
Nebivolol—Headache—Ezetimibe—coronary artery disease	0.000113	0.000768	CcSEcCtD
Nebivolol—Vertigo—Lisinopril—coronary artery disease	0.000112	0.000765	CcSEcCtD
Nebivolol—Syncope—Lisinopril—coronary artery disease	0.000112	0.000763	CcSEcCtD
Nebivolol—Vomiting—Eplerenone—coronary artery disease	0.000112	0.000763	CcSEcCtD
Nebivolol—Nausea—Fenofibrate—coronary artery disease	0.000111	0.000761	CcSEcCtD
Nebivolol—Pruritus—Niacin—coronary artery disease	0.000111	0.00076	CcSEcCtD
Nebivolol—Asthenia—Pravastatin—coronary artery disease	0.000111	0.000759	CcSEcCtD
Nebivolol—Gastrointestinal pain—Furosemide—coronary artery disease	0.000111	0.000757	CcSEcCtD
Nebivolol—Rash—Eplerenone—coronary artery disease	0.000111	0.000757	CcSEcCtD
Nebivolol—Urticaria—Perindopril—coronary artery disease	0.000111	0.000757	CcSEcCtD
Nebivolol—Hypersensitivity—Trandolapril—coronary artery disease	0.000111	0.000756	CcSEcCtD
Nebivolol—Dermatitis—Eplerenone—coronary artery disease	0.000111	0.000756	CcSEcCtD
Nebivolol—Diarrhoea—Valsartan—coronary artery disease	0.000111	0.000756	CcSEcCtD
Nebivolol—Shock—Ramipril—coronary artery disease	0.00011	0.000754	CcSEcCtD
Nebivolol—Hypersensitivity—Enalapril—coronary artery disease	0.00011	0.000753	CcSEcCtD
Nebivolol—Abdominal pain—Perindopril—coronary artery disease	0.00011	0.000753	CcSEcCtD
Nebivolol—Diarrhoea—Olmesartan—coronary artery disease	0.00011	0.000752	CcSEcCtD
Nebivolol—Headache—Eplerenone—coronary artery disease	0.00011	0.000752	CcSEcCtD
Nebivolol—Nervous system disorder—Ramipril—coronary artery disease	0.00011	0.000751	CcSEcCtD
Nebivolol—Thrombocytopenia—Ramipril—coronary artery disease	0.00011	0.00075	CcSEcCtD
Nebivolol—Pruritus—Pravastatin—coronary artery disease	0.00011	0.000748	CcSEcCtD
Nebivolol—Loss of consciousness—Lisinopril—coronary artery disease	0.00011	0.000748	CcSEcCtD
Nebivolol—Nausea—Clopidogrel—coronary artery disease	0.00011	0.000748	CcSEcCtD
Nebivolol—Skin disorder—Ramipril—coronary artery disease	0.000109	0.000744	CcSEcCtD
Nebivolol—Vomiting—Simvastatin—coronary artery disease	0.000109	0.000744	CcSEcCtD
Nebivolol—Hypersensitivity—Telmisartan—coronary artery disease	0.000109	0.000743	CcSEcCtD
Nebivolol—Nausea—Lovastatin—coronary artery disease	0.000109	0.000743	CcSEcCtD
Nebivolol—Rash—Simvastatin—coronary artery disease	0.000108	0.000737	CcSEcCtD
Nebivolol—Dermatitis—Simvastatin—coronary artery disease	0.000108	0.000737	CcSEcCtD
Nebivolol—Asthenia—Trandolapril—coronary artery disease	0.000108	0.000737	CcSEcCtD
Nebivolol—Shock—Timolol—coronary artery disease	0.000108	0.000737	CcSEcCtD
Nebivolol—Urticaria—Furosemide—coronary artery disease	0.000108	0.000735	CcSEcCtD
Nebivolol—Diarrhoea—Niacin—coronary artery disease	0.000108	0.000735	CcSEcCtD
Nebivolol—Nervous system disorder—Timolol—coronary artery disease	0.000108	0.000734	CcSEcCtD
Nebivolol—Asthenia—Enalapril—coronary artery disease	0.000107	0.000734	CcSEcCtD
Nebivolol—Headache—Simvastatin—coronary artery disease	0.000107	0.000733	CcSEcCtD
Nebivolol—Abdominal pain—Furosemide—coronary artery disease	0.000107	0.000732	CcSEcCtD
Nebivolol—Gastrointestinal pain—Losartan—coronary artery disease	0.000107	0.00073	CcSEcCtD
Nebivolol—Dizziness—Valsartan—coronary artery disease	0.000107	0.00073	CcSEcCtD
Nebivolol—Nausea—Ezetimibe—coronary artery disease	0.000107	0.000728	CcSEcCtD
Nebivolol—Skin disorder—Timolol—coronary artery disease	0.000107	0.000727	CcSEcCtD
Nebivolol—Dizziness—Olmesartan—coronary artery disease	0.000106	0.000727	CcSEcCtD
Nebivolol—Pruritus—Trandolapril—coronary artery disease	0.000106	0.000726	CcSEcCtD
Nebivolol—Chest pain—Lisinopril—coronary artery disease	0.000106	0.000725	CcSEcCtD
Nebivolol—Asthenia—Telmisartan—coronary artery disease	0.000106	0.000724	CcSEcCtD
Nebivolol—Pruritus—Enalapril—coronary artery disease	0.000106	0.000723	CcSEcCtD
Nebivolol—Diarrhoea—Pravastatin—coronary artery disease	0.000106	0.000723	CcSEcCtD
Nebivolol—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	0.000105	0.00072	CcSEcCtD
Nebivolol—Pruritus—Telmisartan—coronary artery disease	0.000105	0.000714	CcSEcCtD
Nebivolol—Nausea—Eplerenone—coronary artery disease	0.000104	0.000713	CcSEcCtD
Nebivolol—Dizziness—Niacin—coronary artery disease	0.000104	0.00071	CcSEcCtD
Nebivolol—Urticaria—Losartan—coronary artery disease	0.000104	0.00071	CcSEcCtD
Nebivolol—Abdominal pain—Losartan—coronary artery disease	0.000103	0.000706	CcSEcCtD
Nebivolol—Asthenia—Captopril—coronary artery disease	0.000103	0.000704	CcSEcCtD
Nebivolol—Diarrhoea—Trandolapril—coronary artery disease	0.000103	0.000702	CcSEcCtD
Nebivolol—Vomiting—Valsartan—coronary artery disease	0.000103	0.000702	CcSEcCtD
Nebivolol—Diarrhoea—Enalapril—coronary artery disease	0.000102	0.0007	CcSEcCtD
Nebivolol—Dizziness—Pravastatin—coronary artery disease	0.000102	0.000699	CcSEcCtD
Nebivolol—Vomiting—Olmesartan—coronary artery disease	0.000102	0.000699	CcSEcCtD
Nebivolol—Rash—Valsartan—coronary artery disease	0.000102	0.000696	CcSEcCtD
Nebivolol—Dermatitis—Valsartan—coronary artery disease	0.000102	0.000696	CcSEcCtD
Nebivolol—Nausea—Simvastatin—coronary artery disease	0.000102	0.000695	CcSEcCtD
Nebivolol—Pruritus—Captopril—coronary artery disease	0.000102	0.000694	CcSEcCtD
Nebivolol—Rash—Olmesartan—coronary artery disease	0.000102	0.000693	CcSEcCtD
Nebivolol—Insomnia—Ramipril—coronary artery disease	0.000101	0.000693	CcSEcCtD
Nebivolol—Dermatitis—Olmesartan—coronary artery disease	0.000101	0.000692	CcSEcCtD
Nebivolol—Headache—Valsartan—coronary artery disease	0.000101	0.000692	CcSEcCtD
Nebivolol—Diarrhoea—Telmisartan—coronary artery disease	0.000101	0.00069	CcSEcCtD
Nebivolol—Headache—Olmesartan—coronary artery disease	0.000101	0.000689	CcSEcCtD
Nebivolol—Paraesthesia—Ramipril—coronary artery disease	0.000101	0.000688	CcSEcCtD
Nebivolol—Shock—Lisinopril—coronary artery disease	0.0001	0.000683	CcSEcCtD
Nebivolol—Asthenia—Perindopril—coronary artery disease	0.0001	0.000683	CcSEcCtD
Nebivolol—Dyspnoea—Ramipril—coronary artery disease	0.0001	0.000683	CcSEcCtD
Nebivolol—Vomiting—Niacin—coronary artery disease	0.0001	0.000683	CcSEcCtD
Nebivolol—Hypersensitivity—Furosemide—coronary artery disease	9.99e-05	0.000682	CcSEcCtD
Nebivolol—Somnolence—Ramipril—coronary artery disease	9.97e-05	0.000681	CcSEcCtD
Nebivolol—Thrombocytopenia—Lisinopril—coronary artery disease	9.96e-05	0.00068	CcSEcCtD
Nebivolol—Dizziness—Trandolapril—coronary artery disease	9.95e-05	0.000679	CcSEcCtD
Nebivolol—Insomnia—Timolol—coronary artery disease	9.92e-05	0.000677	CcSEcCtD
Nebivolol—Rash—Niacin—coronary artery disease	9.92e-05	0.000677	CcSEcCtD
Nebivolol—Dermatitis—Niacin—coronary artery disease	9.91e-05	0.000676	CcSEcCtD
Nebivolol—Dizziness—Enalapril—coronary artery disease	9.91e-05	0.000676	CcSEcCtD
Nebivolol—Skin disorder—Lisinopril—coronary artery disease	9.88e-05	0.000675	CcSEcCtD
Nebivolol—Pruritus—Perindopril—coronary artery disease	9.87e-05	0.000674	CcSEcCtD
Nebivolol—Headache—Niacin—coronary artery disease	9.85e-05	0.000673	CcSEcCtD
Nebivolol—Paraesthesia—Timolol—coronary artery disease	9.85e-05	0.000672	CcSEcCtD
Nebivolol—Vomiting—Pravastatin—coronary artery disease	9.85e-05	0.000672	CcSEcCtD
Nebivolol—Diarrhoea—Captopril—coronary artery disease	9.83e-05	0.000671	CcSEcCtD
Nebivolol—Dyspnoea—Timolol—coronary artery disease	9.78e-05	0.000668	CcSEcCtD
Nebivolol—Dizziness—Telmisartan—coronary artery disease	9.77e-05	0.000667	CcSEcCtD
Nebivolol—Rash—Pravastatin—coronary artery disease	9.77e-05	0.000667	CcSEcCtD
Nebivolol—Dermatitis—Pravastatin—coronary artery disease	9.76e-05	0.000666	CcSEcCtD
Nebivolol—Somnolence—Timolol—coronary artery disease	9.75e-05	0.000666	CcSEcCtD
Nebivolol—Asthenia—Furosemide—coronary artery disease	9.73e-05	0.000664	CcSEcCtD
Nebivolol—Headache—Pravastatin—coronary artery disease	9.7e-05	0.000662	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Ramipril—coronary artery disease	9.69e-05	0.000661	CcSEcCtD
Nebivolol—Fatigue—Ramipril—coronary artery disease	9.67e-05	0.00066	CcSEcCtD
Nebivolol—Hypersensitivity—Losartan—coronary artery disease	9.64e-05	0.000658	CcSEcCtD
Nebivolol—Nausea—Valsartan—coronary artery disease	9.61e-05	0.000656	CcSEcCtD
Nebivolol—Pruritus—Furosemide—coronary artery disease	9.59e-05	0.000655	CcSEcCtD
Nebivolol—Nausea—Olmesartan—coronary artery disease	9.56e-05	0.000653	CcSEcCtD
Nebivolol—Vomiting—Trandolapril—coronary artery disease	9.56e-05	0.000653	CcSEcCtD
Nebivolol—Diarrhoea—Perindopril—coronary artery disease	9.54e-05	0.000652	CcSEcCtD
Nebivolol—Vomiting—Enalapril—coronary artery disease	9.52e-05	0.00065	CcSEcCtD
Nebivolol—Dizziness—Captopril—coronary artery disease	9.5e-05	0.000649	CcSEcCtD
Nebivolol—Rash—Trandolapril—coronary artery disease	9.48e-05	0.000647	CcSEcCtD
Nebivolol—Dermatitis—Trandolapril—coronary artery disease	9.47e-05	0.000647	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Timolol—coronary artery disease	9.47e-05	0.000646	CcSEcCtD
Nebivolol—Fatigue—Timolol—coronary artery disease	9.46e-05	0.000646	CcSEcCtD
Nebivolol—Rash—Enalapril—coronary artery disease	9.44e-05	0.000645	CcSEcCtD
Nebivolol—Dermatitis—Enalapril—coronary artery disease	9.44e-05	0.000644	CcSEcCtD
Nebivolol—Headache—Trandolapril—coronary artery disease	9.42e-05	0.000643	CcSEcCtD
Nebivolol—Vomiting—Telmisartan—coronary artery disease	9.39e-05	0.000641	CcSEcCtD
Nebivolol—Asthenia—Losartan—coronary artery disease	9.39e-05	0.000641	CcSEcCtD
Nebivolol—Headache—Enalapril—coronary artery disease	9.38e-05	0.000641	CcSEcCtD
Nebivolol—Nausea—Niacin—coronary artery disease	9.34e-05	0.000638	CcSEcCtD
Nebivolol—Rash—Telmisartan—coronary artery disease	9.32e-05	0.000636	CcSEcCtD
Nebivolol—Dermatitis—Telmisartan—coronary artery disease	9.31e-05	0.000635	CcSEcCtD
Nebivolol—Diarrhoea—Furosemide—coronary artery disease	9.28e-05	0.000633	CcSEcCtD
Nebivolol—Pruritus—Losartan—coronary artery disease	9.26e-05	0.000632	CcSEcCtD
Nebivolol—Headache—Telmisartan—coronary artery disease	9.26e-05	0.000632	CcSEcCtD
Nebivolol—Dizziness—Perindopril—coronary artery disease	9.22e-05	0.00063	CcSEcCtD
Nebivolol—Insomnia—Lisinopril—coronary artery disease	9.2e-05	0.000628	CcSEcCtD
Nebivolol—Nausea—Pravastatin—coronary artery disease	9.2e-05	0.000628	CcSEcCtD
Nebivolol—Gastrointestinal pain—Ramipril—coronary artery disease	9.17e-05	0.000626	CcSEcCtD
Nebivolol—Paraesthesia—Lisinopril—coronary artery disease	9.14e-05	0.000624	CcSEcCtD
Nebivolol—Vomiting—Captopril—coronary artery disease	9.13e-05	0.000624	CcSEcCtD
Nebivolol—Dyspnoea—Lisinopril—coronary artery disease	9.07e-05	0.000619	CcSEcCtD
Nebivolol—Rash—Captopril—coronary artery disease	9.06e-05	0.000618	CcSEcCtD
Nebivolol—Dermatitis—Captopril—coronary artery disease	9.05e-05	0.000618	CcSEcCtD
Nebivolol—Somnolence—Lisinopril—coronary artery disease	9.05e-05	0.000617	CcSEcCtD
Nebivolol—Headache—Captopril—coronary artery disease	9e-05	0.000614	CcSEcCtD
Nebivolol—Gastrointestinal pain—Timolol—coronary artery disease	8.97e-05	0.000612	CcSEcCtD
Nebivolol—Dizziness—Furosemide—coronary artery disease	8.97e-05	0.000612	CcSEcCtD
Nebivolol—Diarrhoea—Losartan—coronary artery disease	8.95e-05	0.000611	CcSEcCtD
Nebivolol—Nausea—Trandolapril—coronary artery disease	8.93e-05	0.00061	CcSEcCtD
Nebivolol—Urticaria—Ramipril—coronary artery disease	8.91e-05	0.000608	CcSEcCtD
Nebivolol—Nausea—Enalapril—coronary artery disease	8.9e-05	0.000607	CcSEcCtD
Nebivolol—Vomiting—Perindopril—coronary artery disease	8.87e-05	0.000605	CcSEcCtD
Nebivolol—Abdominal pain—Ramipril—coronary artery disease	8.87e-05	0.000605	CcSEcCtD
Nebivolol—Rash—Perindopril—coronary artery disease	8.8e-05	0.0006	CcSEcCtD
Nebivolol—Dermatitis—Perindopril—coronary artery disease	8.79e-05	0.0006	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Lisinopril—coronary artery disease	8.78e-05	0.0006	CcSEcCtD
Nebivolol—Nausea—Telmisartan—coronary artery disease	8.78e-05	0.000599	CcSEcCtD
Nebivolol—Fatigue—Lisinopril—coronary artery disease	8.77e-05	0.000599	CcSEcCtD
Nebivolol—Headache—Perindopril—coronary artery disease	8.74e-05	0.000597	CcSEcCtD
Nebivolol—Urticaria—Timolol—coronary artery disease	8.71e-05	0.000595	CcSEcCtD
Nebivolol—Abdominal pain—Timolol—coronary artery disease	8.67e-05	0.000592	CcSEcCtD
Nebivolol—Dizziness—Losartan—coronary artery disease	8.65e-05	0.000591	CcSEcCtD
Nebivolol—Vomiting—Furosemide—coronary artery disease	8.62e-05	0.000589	CcSEcCtD
Nebivolol—Rash—Furosemide—coronary artery disease	8.55e-05	0.000584	CcSEcCtD
Nebivolol—Dermatitis—Furosemide—coronary artery disease	8.54e-05	0.000583	CcSEcCtD
Nebivolol—Nausea—Captopril—coronary artery disease	8.53e-05	0.000583	CcSEcCtD
Nebivolol—Headache—Furosemide—coronary artery disease	8.5e-05	0.00058	CcSEcCtD
Nebivolol—Gastrointestinal pain—Lisinopril—coronary artery disease	8.32e-05	0.000568	CcSEcCtD
Nebivolol—Vomiting—Losartan—coronary artery disease	8.32e-05	0.000568	CcSEcCtD
Nebivolol—Nausea—Perindopril—coronary artery disease	8.29e-05	0.000566	CcSEcCtD
Nebivolol—Hypersensitivity—Ramipril—coronary artery disease	8.27e-05	0.000564	CcSEcCtD
Nebivolol—Rash—Losartan—coronary artery disease	8.25e-05	0.000563	CcSEcCtD
Nebivolol—Dermatitis—Losartan—coronary artery disease	8.24e-05	0.000563	CcSEcCtD
Nebivolol—Headache—Losartan—coronary artery disease	8.2e-05	0.00056	CcSEcCtD
Nebivolol—Urticaria—Lisinopril—coronary artery disease	8.08e-05	0.000552	CcSEcCtD
Nebivolol—Hypersensitivity—Timolol—coronary artery disease	8.08e-05	0.000552	CcSEcCtD
Nebivolol—Nausea—Furosemide—coronary artery disease	8.05e-05	0.00055	CcSEcCtD
Nebivolol—Asthenia—Ramipril—coronary artery disease	8.05e-05	0.00055	CcSEcCtD
Nebivolol—Abdominal pain—Lisinopril—coronary artery disease	8.04e-05	0.000549	CcSEcCtD
Nebivolol—Pruritus—Ramipril—coronary artery disease	7.94e-05	0.000542	CcSEcCtD
Nebivolol—Asthenia—Timolol—coronary artery disease	7.87e-05	0.000537	CcSEcCtD
Nebivolol—Nausea—Losartan—coronary artery disease	7.77e-05	0.000531	CcSEcCtD
Nebivolol—Pruritus—Timolol—coronary artery disease	7.76e-05	0.00053	CcSEcCtD
Nebivolol—Diarrhoea—Ramipril—coronary artery disease	7.68e-05	0.000524	CcSEcCtD
Nebivolol—Diarrhoea—Timolol—coronary artery disease	7.5e-05	0.000512	CcSEcCtD
Nebivolol—Hypersensitivity—Lisinopril—coronary artery disease	7.5e-05	0.000512	CcSEcCtD
Nebivolol—Dizziness—Ramipril—coronary artery disease	7.42e-05	0.000506	CcSEcCtD
Nebivolol—Asthenia—Lisinopril—coronary artery disease	7.3e-05	0.000498	CcSEcCtD
Nebivolol—Dizziness—Timolol—coronary artery disease	7.25e-05	0.000495	CcSEcCtD
Nebivolol—Pruritus—Lisinopril—coronary artery disease	7.2e-05	0.000491	CcSEcCtD
Nebivolol—Vomiting—Ramipril—coronary artery disease	7.13e-05	0.000487	CcSEcCtD
Nebivolol—Rash—Ramipril—coronary artery disease	7.07e-05	0.000483	CcSEcCtD
Nebivolol—Dermatitis—Ramipril—coronary artery disease	7.07e-05	0.000482	CcSEcCtD
Nebivolol—Headache—Ramipril—coronary artery disease	7.03e-05	0.00048	CcSEcCtD
Nebivolol—Vomiting—Timolol—coronary artery disease	6.97e-05	0.000476	CcSEcCtD
Nebivolol—Diarrhoea—Lisinopril—coronary artery disease	6.96e-05	0.000475	CcSEcCtD
Nebivolol—Rash—Timolol—coronary artery disease	6.92e-05	0.000472	CcSEcCtD
Nebivolol—Dermatitis—Timolol—coronary artery disease	6.91e-05	0.000472	CcSEcCtD
Nebivolol—Headache—Timolol—coronary artery disease	6.87e-05	0.000469	CcSEcCtD
Nebivolol—Dizziness—Lisinopril—coronary artery disease	6.73e-05	0.000459	CcSEcCtD
Nebivolol—Nausea—Ramipril—coronary artery disease	6.66e-05	0.000455	CcSEcCtD
Nebivolol—Nausea—Timolol—coronary artery disease	6.51e-05	0.000445	CcSEcCtD
Nebivolol—Vomiting—Lisinopril—coronary artery disease	6.47e-05	0.000442	CcSEcCtD
Nebivolol—Rash—Lisinopril—coronary artery disease	6.42e-05	0.000438	CcSEcCtD
Nebivolol—Dermatitis—Lisinopril—coronary artery disease	6.41e-05	0.000438	CcSEcCtD
Nebivolol—Headache—Lisinopril—coronary artery disease	6.37e-05	0.000435	CcSEcCtD
Nebivolol—Nausea—Lisinopril—coronary artery disease	6.04e-05	0.000413	CcSEcCtD
Nebivolol—ADRB2—Signaling by GPCR—IL6R—coronary artery disease	7.86e-06	0.000141	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—AGTR1—coronary artery disease	7.86e-06	0.000141	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—CXCL10—coronary artery disease	7.86e-06	0.000141	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—PLG—coronary artery disease	7.83e-06	0.000141	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—APOA5—coronary artery disease	7.83e-06	0.000141	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—ADRB2—coronary artery disease	7.8e-06	0.00014	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—CCL2—coronary artery disease	7.71e-06	0.000139	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—PRKCE—coronary artery disease	7.7e-06	0.000138	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—JAK2—coronary artery disease	7.69e-06	0.000138	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—IL6R—coronary artery disease	7.69e-06	0.000138	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—CXCL10—coronary artery disease	7.68e-06	0.000138	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—P4HB—coronary artery disease	7.68e-06	0.000138	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—SOCS1—coronary artery disease	7.68e-06	0.000138	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—PLG—coronary artery disease	7.66e-06	0.000138	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—S100B—coronary artery disease	7.66e-06	0.000138	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—SOCS3—coronary artery disease	7.58e-06	0.000136	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—PLA2G1B—coronary artery disease	7.54e-06	0.000136	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—PRKCE—coronary artery disease	7.53e-06	0.000135	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—JAK2—coronary artery disease	7.52e-06	0.000135	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—SOCS1—coronary artery disease	7.51e-06	0.000135	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—KITLG—coronary artery disease	7.49e-06	0.000135	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—TGFBR2—coronary artery disease	7.49e-06	0.000135	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—S100B—coronary artery disease	7.49e-06	0.000135	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—ADRB2—coronary artery disease	7.46e-06	0.000134	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—SOCS3—coronary artery disease	7.42e-06	0.000133	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—PRKCE—coronary artery disease	7.36e-06	0.000132	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—JAK2—coronary artery disease	7.36e-06	0.000132	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—SOCS1—coronary artery disease	7.34e-06	0.000132	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—TGFBR2—coronary artery disease	7.33e-06	0.000132	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—KITLG—coronary artery disease	7.33e-06	0.000132	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—S100B—coronary artery disease	7.33e-06	0.000132	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—STAT5A—coronary artery disease	7.33e-06	0.000132	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—MMP3—coronary artery disease	7.33e-06	0.000132	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—SOCS3—coronary artery disease	7.26e-06	0.000131	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—KITLG—coronary artery disease	7.17e-06	0.000129	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—TGFBR2—coronary artery disease	7.17e-06	0.000129	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—MMP3—coronary artery disease	7.17e-06	0.000129	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—STAT5A—coronary artery disease	7.17e-06	0.000129	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—VCAN—coronary artery disease	7.11e-06	0.000128	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—APOB—coronary artery disease	7.08e-06	0.000127	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—ALDOA—coronary artery disease	7.05e-06	0.000127	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—CXCL8—coronary artery disease	7.02e-06	0.000126	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—STAT5A—coronary artery disease	7.01e-06	0.000126	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—MMP3—coronary artery disease	7.01e-06	0.000126	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—JAK2—coronary artery disease	6.98e-06	0.000126	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—EDN1—coronary artery disease	6.97e-06	0.000125	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—APOB—coronary artery disease	6.93e-06	0.000125	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—CCL5—coronary artery disease	6.91e-06	0.000124	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—CXCL8—coronary artery disease	6.87e-06	0.000124	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—DCN—coronary artery disease	6.85e-06	0.000123	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—JAK2—coronary artery disease	6.83e-06	0.000123	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—EDN1—coronary artery disease	6.82e-06	0.000123	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—FGF1—coronary artery disease	6.81e-06	0.000123	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—CSF2—coronary artery disease	6.81e-06	0.000123	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—APOB—coronary artery disease	6.77e-06	0.000122	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—CCL5—coronary artery disease	6.76e-06	0.000122	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—LPL—coronary artery disease	6.76e-06	0.000122	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—CXCL8—coronary artery disease	6.71e-06	0.000121	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—MEF2C—coronary artery disease	6.7e-06	0.000121	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—RPS6KB1—coronary artery disease	6.7e-06	0.000121	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—JAK2—coronary artery disease	6.68e-06	0.00012	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—EDN1—coronary artery disease	6.66e-06	0.00012	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—CSF2—coronary artery disease	6.66e-06	0.00012	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—FGF1—coronary artery disease	6.66e-06	0.00012	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—ALDH2—coronary artery disease	6.66e-06	0.00012	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—CCL5—coronary artery disease	6.61e-06	0.000119	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—LPL—coronary artery disease	6.61e-06	0.000119	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—RPS6KB1—coronary artery disease	6.55e-06	0.000118	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—MEF2C—coronary artery disease	6.55e-06	0.000118	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—ITGB3—coronary artery disease	6.53e-06	0.000117	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—FGF1—coronary artery disease	6.51e-06	0.000117	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—CSF2—coronary artery disease	6.51e-06	0.000117	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—LIPC—coronary artery disease	6.49e-06	0.000117	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—HBA1—coronary artery disease	6.49e-06	0.000117	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—CYP2C19—coronary artery disease	6.49e-06	0.000117	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—PIK3C2A—coronary artery disease	6.49e-06	0.000117	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—LPL—coronary artery disease	6.47e-06	0.000116	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—APOC3—coronary artery disease	6.45e-06	0.000116	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—LDLR—coronary artery disease	6.41e-06	0.000115	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—RPS6KB1—coronary artery disease	6.41e-06	0.000115	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—MEF2C—coronary artery disease	6.41e-06	0.000115	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—ITGB3—coronary artery disease	6.39e-06	0.000115	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—CXCL8—coronary artery disease	6.37e-06	0.000115	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—PPP2CA—coronary artery disease	6.34e-06	0.000114	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—SLC9A1—coronary artery disease	6.33e-06	0.000114	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—GSTT1—coronary artery disease	6.33e-06	0.000114	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—GCLC—coronary artery disease	6.26e-06	0.000113	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—CETP—coronary artery disease	6.26e-06	0.000113	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—ITGB3—coronary artery disease	6.25e-06	0.000112	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—CXCL8—coronary artery disease	6.24e-06	0.000112	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—PRKCD—coronary artery disease	6.23e-06	0.000112	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—PPP2CA—coronary artery disease	6.2e-06	0.000112	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—SDC1—coronary artery disease	6.19e-06	0.000111	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—CXCL8—coronary artery disease	6.1e-06	0.00011	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—HTR2A—coronary artery disease	6.1e-06	0.00011	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—PRKCD—coronary artery disease	6.09e-06	0.00011	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—C3—coronary artery disease	6.09e-06	0.000109	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—PPP2CA—coronary artery disease	6.07e-06	0.000109	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—HTR2A—coronary artery disease	5.96e-06	0.000107	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—PRKCD—coronary artery disease	5.96e-06	0.000107	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—C3—coronary artery disease	5.95e-06	0.000107	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—PSMA6—coronary artery disease	5.85e-06	0.000105	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—PSMB5—coronary artery disease	5.85e-06	0.000105	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—HTR2A—coronary artery disease	5.83e-06	0.000105	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—C3—coronary artery disease	5.82e-06	0.000105	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—HIF1A—coronary artery disease	5.81e-06	0.000104	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—AGT—coronary artery disease	5.78e-06	0.000104	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—CTGF—coronary artery disease	5.71e-06	0.000103	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—HIF1A—coronary artery disease	5.68e-06	0.000102	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—LEP—coronary artery disease	5.67e-06	0.000102	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—APOE—coronary artery disease	5.67e-06	0.000102	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—HMGCR—coronary artery disease	5.66e-06	0.000102	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—GOT2—coronary artery disease	5.66e-06	0.000102	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—AGT—coronary artery disease	5.66e-06	0.000102	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—APOA1—coronary artery disease	5.6e-06	0.000101	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—HIF1A—coronary artery disease	5.55e-06	9.99e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—KDR—coronary artery disease	5.55e-06	9.99e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—APOE—coronary artery disease	5.54e-06	9.97e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—LEP—coronary artery disease	5.54e-06	9.97e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—AGT—coronary artery disease	5.53e-06	9.95e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—MAPK14—coronary artery disease	5.52e-06	9.92e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—APOA1—coronary artery disease	5.48e-06	9.86e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—KDR—coronary artery disease	5.43e-06	9.77e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—APOE—coronary artery disease	5.42e-06	9.75e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—LEP—coronary artery disease	5.42e-06	9.75e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—ESR1—coronary artery disease	5.41e-06	9.73e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—MAPK14—coronary artery disease	5.39e-06	9.7e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—APOA1—coronary artery disease	5.36e-06	9.64e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—F2—coronary artery disease	5.34e-06	9.61e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—FN1—coronary artery disease	5.34e-06	9.61e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—IL6ST—coronary artery disease	5.32e-06	9.57e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—KDR—coronary artery disease	5.31e-06	9.55e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—ESR1—coronary artery disease	5.29e-06	9.52e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—NFKBIA—coronary artery disease	5.28e-06	9.5e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—MAPK14—coronary artery disease	5.28e-06	9.49e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—F2—coronary artery disease	5.23e-06	9.4e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—FN1—coronary artery disease	5.23e-06	9.4e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—PLCB1—coronary artery disease	5.21e-06	9.37e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—IL6ST—coronary artery disease	5.21e-06	9.37e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—ESR1—coronary artery disease	5.17e-06	9.31e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—NFKBIA—coronary artery disease	5.17e-06	9.29e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—KIT—coronary artery disease	5.11e-06	9.2e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—F2—coronary artery disease	5.11e-06	9.2e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—FN1—coronary artery disease	5.11e-06	9.2e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—IL6ST—coronary artery disease	5.09e-06	9.16e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—NFKBIA—coronary artery disease	5.05e-06	9.09e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—ABCA1—coronary artery disease	5.05e-06	9.08e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—KIT—coronary artery disease	5e-06	9e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—GSK3B—coronary artery disease	4.91e-06	8.83e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—KIT—coronary artery disease	4.89e-06	8.8e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—GGT1—coronary artery disease	4.89e-06	8.79e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—GOT1—coronary artery disease	4.89e-06	8.79e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—POMC—coronary artery disease	4.87e-06	8.76e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—CREB1—coronary artery disease	4.87e-06	8.76e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—GSK3B—coronary artery disease	4.8e-06	8.64e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—CCL2—coronary artery disease	4.76e-06	8.57e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—POMC—coronary artery disease	4.76e-06	8.57e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—CREB1—coronary artery disease	4.76e-06	8.57e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—IL6R—coronary artery disease	4.75e-06	8.54e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—GSK3B—coronary artery disease	4.69e-06	8.44e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—IGF1—coronary artery disease	4.68e-06	8.42e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—MAPK1—coronary artery disease	4.66e-06	8.38e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—CCL2—coronary artery disease	4.66e-06	8.38e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—CREB1—coronary artery disease	4.66e-06	8.38e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—POMC—coronary artery disease	4.66e-06	8.38e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—IL6R—coronary artery disease	4.65e-06	8.36e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—IGF1—coronary artery disease	4.58e-06	8.24e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—MAPK1—coronary artery disease	4.56e-06	8.2e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—CCL2—coronary artery disease	4.56e-06	8.2e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—IL6R—coronary artery disease	4.54e-06	8.17e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—IGF1—coronary artery disease	4.48e-06	8.06e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—MAPK1—coronary artery disease	4.46e-06	8.02e-05	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—PIK3CA—coronary artery disease	4.45e-06	8.01e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—SERPINE1—coronary artery disease	4.45e-06	8e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—GSTP1—coronary artery disease	4.39e-06	7.9e-05	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—PIK3CA—coronary artery disease	4.36e-06	7.84e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—PPARGC1A—coronary artery disease	4.35e-06	7.83e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—SERPINE1—coronary artery disease	4.35e-06	7.82e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—HMOX1—coronary artery disease	4.33e-06	7.79e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—FGF2—coronary artery disease	4.3e-06	7.74e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—CAT—coronary artery disease	4.27e-06	7.69e-05	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—PIK3CA—coronary artery disease	4.26e-06	7.66e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—SERPINE1—coronary artery disease	4.25e-06	7.65e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—NOS3—coronary artery disease	4.25e-06	7.64e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—FGF2—coronary artery disease	4.21e-06	7.57e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—NOS3—coronary artery disease	4.15e-06	7.47e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—APOB—coronary artery disease	4.15e-06	7.46e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—JAK2—coronary artery disease	4.13e-06	7.42e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—FGF2—coronary artery disease	4.12e-06	7.41e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—NOS3—coronary artery disease	4.06e-06	7.3e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—PIK3CA—coronary artery disease	4.04e-06	7.27e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—JAK2—coronary artery disease	4.04e-06	7.26e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—GSTM1—coronary artery disease	4.04e-06	7.26e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—LPL—coronary artery disease	3.96e-06	7.12e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—PIK3CA—coronary artery disease	3.96e-06	7.12e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—JAK2—coronary artery disease	3.95e-06	7.1e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—PIK3CA—coronary artery disease	3.87e-06	6.96e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—GPX1—coronary artery disease	3.86e-06	6.95e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—CXCL8—coronary artery disease	3.77e-06	6.77e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—CD36—coronary artery disease	3.76e-06	6.77e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—PPP2CA—coronary artery disease	3.72e-06	6.68e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—CXCL8—coronary artery disease	3.68e-06	6.63e-05	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—AKT1—coronary artery disease	3.64e-06	6.54e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—CASP3—coronary artery disease	3.6e-06	6.48e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—CXCL8—coronary artery disease	3.6e-06	6.48e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—IL6—coronary artery disease	3.58e-06	6.44e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—MTHFR—coronary artery disease	3.57e-06	6.41e-05	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—AKT1—coronary artery disease	3.56e-06	6.4e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—CASP3—coronary artery disease	3.53e-06	6.34e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—CCND1—coronary artery disease	3.51e-06	6.31e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—IL6—coronary artery disease	3.5e-06	6.3e-05	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—AKT1—coronary artery disease	3.48e-06	6.26e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—CASP3—coronary artery disease	3.45e-06	6.2e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—CCND1—coronary artery disease	3.43e-06	6.17e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—IL6—coronary artery disease	3.43e-06	6.16e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—MMP9—coronary artery disease	3.41e-06	6.13e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—AGT—coronary artery disease	3.39e-06	6.1e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—CCND1—coronary artery disease	3.36e-06	6.04e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—MMP9—coronary artery disease	3.33e-06	5.99e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—APOE—coronary artery disease	3.32e-06	5.97e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—AKT1—coronary artery disease	3.3e-06	5.94e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—APOA1—coronary artery disease	3.28e-06	5.9e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—MMP9—coronary artery disease	3.26e-06	5.86e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—AKT1—coronary artery disease	3.23e-06	5.81e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—AKT1—coronary artery disease	3.16e-06	5.68e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—VEGFA—coronary artery disease	3.06e-06	5.5e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—VEGFA—coronary artery disease	2.99e-06	5.38e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—VEGFA—coronary artery disease	2.93e-06	5.26e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—PPARG—coronary artery disease	2.89e-06	5.2e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—POMC—coronary artery disease	2.85e-06	5.13e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—TGFB1—coronary artery disease	2.81e-06	5.05e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—MAPK1—coronary artery disease	2.75e-06	4.95e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—TGFB1—coronary artery disease	2.75e-06	4.94e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—MAPK1—coronary artery disease	2.69e-06	4.84e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—TGFB1—coronary artery disease	2.69e-06	4.83e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—MAPK1—coronary artery disease	2.63e-06	4.74e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—ALB—coronary artery disease	2.6e-06	4.68e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—NOS3—coronary artery disease	2.49e-06	4.47e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—PIK3CA—coronary artery disease	2.39e-06	4.3e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—PIK3CA—coronary artery disease	2.34e-06	4.2e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—PIK3CA—coronary artery disease	2.28e-06	4.11e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—PTGS2—coronary artery disease	2.27e-06	4.09e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—IL6—coronary artery disease	2.12e-06	3.81e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—IL6—coronary artery disease	2.07e-06	3.72e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—IL6—coronary artery disease	2.02e-06	3.64e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—AKT1—coronary artery disease	1.95e-06	3.51e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—AKT1—coronary artery disease	1.91e-06	3.43e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—AKT1—coronary artery disease	1.87e-06	3.36e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—PIK3CA—coronary artery disease	1.4e-06	2.52e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—AKT1—coronary artery disease	1.14e-06	2.06e-05	CbGpPWpGaD
